U.S,Ca:18006380796

Contact Us

Get 30% Free Customization on This Report

Published Date: December, 2018

Cancer Biomarkers Market (Biomolecule Type - Genetic, Epigenetic, Metabolic, and Proteomic; Cancer Type - Breast, Lung, Prostate, Colorectal, Stomach, Skin, Ovarian, Blood Cancer, and Others; Application - Diagnostics, Prognostics, Risk Assessment; End-Users - Hospitals, Speciality Centers, and Academic, Cancer Research Centers): Global Industry Analysis, Trends, Size, Share and Forecasts to 2024


Request Discount Enquire Before Buying

A recent report published by Infinium Global Research on cancer biomarkers market provides in-depth analysis of segments and sub-segments in the global as well as regional cancer biomarkers market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional cancer biomarkers market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global cancer biomarkers market. According to the report, the global cancer biomarkers market is projected to grow at a CAGR of 10.5% over the forecast period of 2018-2024.

 

Segment Covered

The report on global cancer biomarkers market covers segments such as biomolecule type, cancer type, application, and end-users. On the basis of biomolecule type, the sub-markets include genetic, epigenetic, metabolic, and proteomic. On the basis of cancer type, the sub-markets include breast cancer, lung cancer, prostate cancer, colorectal cancer, stomach cancer, skin cancer, ovarian cancer, blood cancer, and others. On the basis of application, the sub-markets include diagnostics, prognostics, risk assessment, drug discovery and development, and others. On the basis of end-users, the sub-markets include hospitals, speciality centers, and academic and cancer research centers.

 

Geographic Coverage

The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography are provided over the period of 2016-2024. The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region, as it is the largest market in this region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China.

 

Companies Profiled:

The report provides profiles of the companies in the market such as F. Hoffmann-La Roche Ltd, Abbott Laboratories, GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc, Becton, Dickinson and Company, Hologic, Inc., Genomic Health, Inc, Agilent Technologies, Inc., and Illumina, Inc..

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of cancer biomarkers market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

The Infinium Advantages

Analyst Support

Get free analyst support for the queries before and post purchasing report.

Customer Satisfaction

Be assured of 100% customer satisfaction about the research and get 24X7 customer support.

400% Growth

Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.

Related Reports

sign up for our newsletter